Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation

Heart

Volumn 92, Issue 11, 2006, Pages 1623-1627

  Date, Taro ^a   Yamane, T ^a   Inada, K ^a   Matsuo, S ^a   Miyanaga, S ^a   Sugimoto, K ^a   Shibayama, K ^a   Taniguchi, I ^a   Mochizuki, S ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY VEIN; SUPRAVENTRICULAR TACHYCARDIA;

ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PULMONARY VEINS;

EID: 33750318718     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.083022     Document Type: Article

References (25)

1. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;97:1402-12.
2. Nakamura M, Endo H, Nasu M, et al. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart 2002;87:131-5.
3. Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 2002;144:834-9.
4. Mueller T, Gegenhuber A, Poelz W, et al. Diagnostic accuracy of B type natriuretic peptide and amino terminal pro BNP in the emergency diagnosis of heart failure. Heart 2005;91:606-12.
5. Jourdain P, Bellorini M, Funck F, et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur J Heart Fail 2002;4:263-7.
6. Inoue SI, Murakami YO, Sano K, et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000;6:92-6.
7. Silvet H, Young-Xu Y, Walleigh D, et al. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003;92:1124-7.
8. Arima M, Kanoh T, Kawano Y, et al. Plasma levels of brain natriuretic peptide increase in patients with idiopathic bilateral atrial dilatation. Cardiology 2002;97:12-7.
9. Horie H, Tsutamoto T, Minai K, et al. Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome. Jpn Circ J 2000;64:965-70.
10. Ellinor PT, Low AF, Patton KK, et al. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 2005;45:82-6.
11. Ohta Y, Shimada T, Yoshitomi H, et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol 2001;17:415-20.
12. Mabuchi N, Tsutamoto T, Maeda K, et al. Plasma cardiac natriuretic peptides as biochemical markers of the recurrence of atrial fibrillation in patients with congestive hearts failure. Jpn Circ J 2000;64:765-71.
13. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
14. Jais P, Sanders P, Hsu LF, et al. Catheter ablation for atrial fibrillation. Heart, 2005;91, 7-9.
15. Yamane T, Shah DC, Jais P, et al. Electrogram polarity reversal as an additional indicator of breakthroughs from the left atrium to the pulmonary veins. J Am Coll Cardiol 2002;39:1337-44.
16. Haissaguerre M, Shah DC, Jais P, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000;102:2463-5.
17. Jais P, Hocini M, Macle L, et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002;106:2479-85.
18. Schiller NB, Shah PM, Crawford M, American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
19. Rossi A, Enriquez-Sarano M, Burnett JC Jr, et al. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler- echocardiographic study. J Am Coll Cardiol 2000;35:1256-62.
20. Rashidi A. Mechanism of high brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004;93:670.
21. Tuinenburg AE, Brundel BJ, Van Gelder IC, et al. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:827-35.
22. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4.
23. Nerheim P, Birger-Botkin S, Piracha L, et al. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 2004;110:247-52.
24. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003;107:2920-5.
25. Hsu LF, Jais P, Sanders P, et al. Catheter ablation of atrial fibrillation in congestive heart failure. N Engl J Med 2004;351:2373-83.